About ADM
ADM is a company based in Paterna (Spain) founded in 2003 was acquired by ADM in June 2017. It operates as a Direct-to-Consumer (D2C) and B2B2C. ADM has raised $330.12 thousand across 9 funding rounds from investors including Capsa Healthcare, ADM and European Union. ADM offers products and services including Human Nutrition Solutions, Animal Nutrition Products, Pet Nutrition Products, and Industrial Biosolutions. ADM operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
- Headquarter Paterna, Spain
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$330.12 K (USD)
in 9 rounds
-
Latest Funding Round
$673.55 K (USD), Grant
Jun 01, 2021
-
Investors
Capsa Healthcare
& 5 more
-
Employee Count
Not available
-
Acquired by
ADM
(Jun 01, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ADM
ADM offers a comprehensive portfolio of products and services, including Human Nutrition Solutions, Animal Nutrition Products, Pet Nutrition Products, and Industrial Biosolutions.
Ingredients for food and beverages are provided by ADM.
Customized feed solutions for animals are offered by ADM.
Innovative pet food products are developed by ADM experts.
Sustainable industrial solutions are provided by ADM globally.
Funding Insights of ADM
ADM has successfully raised a total of $330.12K across 9 strategic funding rounds. The most recent funding activity was a Grant round of $673.55 thousand completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ADM
ADM has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Capsa Healthcare, ADM and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Talde Private Equity is engaged in investing and financing Spanish SMEs.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Scientific research and technological development are conducted across multiple fields.
|
Locked | Locked | Locked |
Investor details for ADM
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ADM
Investment portfolio details for ADM
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ADM
Detailed financials for ADM
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Adm Comparisons
Peer comparison for ADM
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ADM
ADM operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
|
| Locked | Locked | Locked |
Dental implants and regenerative dentistry products are developed.
|
Detailed competitors of ADM
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Adm
Complete news archive for ADM
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ADM
ADM was founded in 2003.
ADM is headquartered in Paterna, Spain. It is registered at Paterna, Valencian Community, Spain.
ADM is a funded company, having raised a total of $330.12K across 9 funding rounds to date.
ADM is established as a key player in the nutrition industry, focusing on both human and animal sectors. Solutions are developed using natural ingredients to ensure safe, healthy, and sustainable nutrition worldwide. A wide portfolio of products is offered, ranging from food ingredients to complete animal feed solutions. Services are extended to industrial biosolutions with an emphasis on sustainability. Innovation is prioritized through partnerships and investments in food and agriculture technology. Operations are managed globally, adding value across the nutrition supply chain with a significant international footprint.
ADM's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
ADM offers Human Nutrition Solutions, Animal Nutrition Products, Pet Nutrition Products, and Industrial Biosolutions.
ADM has 6 investors. Key investors include Capsa Healthcare, ADM, European Union, CSIC, and Natraceutical Group.